Title |
A Clinical Review of the Treatment of Catatonia
|
---|---|
Published in |
Frontiers in Psychiatry, December 2014
|
DOI | 10.3389/fpsyt.2014.00181 |
Pubmed ID | |
Authors |
Pascal Sienaert, Dirk M. Dhossche, Davy Vancampfort, Marc De Hert, Gábor Gazdag |
Abstract |
Catatonia is a severe motor syndrome with an estimated prevalence among psychiatric inpatients of about 10%. At times, it is life-threatening especially in its malignant form when complicated by fever and autonomic disturbances. Catatonia can accompany many different psychiatric illnesses and somatic diseases. In order to recognize the catatonic syndrome, apart from thorough and repeated observation, a clinical examination is needed. A screening instrument, such as the Bush-Francis Catatonia Rating Scale, can guide the clinician through the neuropsychiatric examination. Although severe and life-threatening, catatonia has a good prognosis. Research on the treatment of catatonia is scarce, but there is overwhelming clinical evidence of the efficacy of benzodiazepines, such as lorazepam, and electroconvulsive therapy. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 2 | 13% |
Germany | 1 | 7% |
Myanmar | 1 | 7% |
Unknown | 11 | 73% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 67% |
Practitioners (doctors, other healthcare professionals) | 2 | 13% |
Unknown | 3 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | <1% |
Mexico | 1 | <1% |
Nigeria | 1 | <1% |
Japan | 1 | <1% |
United States | 1 | <1% |
Unknown | 367 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 52 | 14% |
Student > Bachelor | 48 | 13% |
Other | 37 | 10% |
Researcher | 34 | 9% |
Student > Master | 34 | 9% |
Other | 72 | 19% |
Unknown | 95 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 184 | 49% |
Neuroscience | 20 | 5% |
Psychology | 18 | 5% |
Agricultural and Biological Sciences | 15 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 13 | 3% |
Other | 21 | 6% |
Unknown | 101 | 27% |